1 We examined the e ects of endogenous prostaglandin E 2 (PGE 2 ) on the production of interleukin-6 (IL-6), macrophage colony stimulating factor (M-CSF), and vascular endothelial growth factor (VEGF) by interleukin-1b (IL-1b)-stimulated human synovial ®broblasts. 2 NS-398 (1 mM), a cyclo-oxygenase-2 (COX-2) inhibitor, inhibited IL-6 and VEGF production (35+4% and 26+2%, respectively) but enhanced M-CSF production (38+4%) by IL-1b (1 ng ml 71 ) in synovial ®broblasts isolated from patients with osteoarthritis (OA) and rheumatoid arthritis (RA). Exogenous PGE 2 completely abolished the e ects of NS-398 on the production of each mediator by OA ®broblasts stimulated with IL-1b. 3 8-Bromo cyclic AMP and dibutyryl cyclic AMP, cyclic AMP analogues, mimicked the e ects of PGE 2 on IL-6, M-CSF, and VEGF production by OA ®broblasts. 4 The EP 2 selective receptor agonist ONO-AE1-259 (2 nM) and the EP 4 selective receptor agonist ONO-AE1-329 (2 or 20 nM), but not the EP 1 selective receptor agonist ONO-DI-004 (1 mM) and the EP 3 selective receptor agonist ONO-AE-248 (1 mM), replaced the e ects of PGE 2 on IL-6, M-CSF, and VEGF production by OA and RA ®broblasts stimulated with IL-1b in the presence of NS-398. 5 Both OA and RA ®broblasts expressed mRNA encoding EP 2 and EP 4 but not EP 1 receptors. In addition, up-regulation of EP 2 and EP 4 receptor mRNAs was observed at 3 h after IL-1b treatment. 6 These results suggest that endogenous PGE 2 regulates the production of IL-6, M-CSF, and VEGF by IL-1b-stimulated human synovial ®broblasts through the activation of EP 2 and EP 4 receptors with increase in cyclic AMP.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.